Atlas Trials

Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia

Clinical trial NCT03009721 · UNKNOWN

Trial details

NCT number
NCT03009721
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Study type
OBSERVATIONAL
HypertensionDyslipidemias
Start date
2016-08-01
Primary completion
2018-06-01
Enrollment
9707

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.